{
    "code": "60001086",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001086",
    "time": "2021-08-06 03:13:20",
    "許可證字號": "衛部菌疫輸字第001086號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/08\/28",
    "發證日期": "107\/08\/28",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000108607",
    "中文品名": "血甯博皮下注射劑30毫克\/毫升",
    "英文品名": "HEMLIBRA SC Injection 30 mg\/mL",
    "適應症": "適用於帶有或未帶有第八凝血因子抗體的A型血友病（先天性第八凝血因子缺乏）病人之出血事件常規性預防。",
    "劑型": "27D注射液劑",
    "包裝": "另附皮下注射配件組(內含取藥針頭1支、皮下注射安全針頭1支、針筒2支、酒精棉片2塊)。每小瓶1毫升，100瓶以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分",
    "監視期限": "112\/08\/28",
    "主成分略述": "emicizumab",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "1438501100  台灣中外製藥股份有限公司",
    "申請商地址": "台北市松山區敦化北路260號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0526100  UTSUNOMIYA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.",
            "製造廠廠址": "16-3 KIYOHARA KOGYODANCHI, UTSUNOMIYA-CITY, TOCHIGI, JAPAN",
            "製造廠公司地址": "5-1 UKIMA 5-CHOME,KITA-KU,TOKYO,JAPAN",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "皮下注射配件組包裝廠"
        },
        {
            "製造廠名稱": "FJP0533100  UKIMA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.",
            "製造廠廠址": "5-1, UKIMA 5-CHOME, KITA-KU, TOKYO JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FJP0621100  Bushu Pharmaceuticals Ltd. Kawagoe Factory",
            "製造廠廠址": "1 Takeno, Kawagoe, Saitama, 350-0801, Japan",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012103500",
            "成分名稱": "emicizumab",
            "含量描述": "",
            "含量": "30.0000000000",
            "單位": "MG\/ML"
        }
    ],
    "仿單外盒": [
        {
            "title": "20201028 Hemlibra _TPI v4(自行變更)-110-07-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001086&Seq=002&Type=9"
        },
        {
            "title": "Hemlibra SC血甯博皮下注射劑30 150毫克 _核定本-108-10-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001086&Seq=001&Type=9"
        },
        {
            "title": "HEM30mg_外盒-109-04-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001086&Seq=008&Type=8"
        },
        {
            "title": "HEM 30mg label-109-04-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001086&Seq=007&Type=8"
        },
        {
            "title": "Self Injection Set box0513-108-05-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001086&Seq=006&Type=8"
        },
        {
            "title": "Self injection Set box-108-03-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001086&Seq=005&Type=8"
        },
        {
            "title": "HEM vial label_30mg-107-12-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001086&Seq=004&Type=8"
        },
        {
            "title": "HEM_sticker_30-107-12-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001086&Seq=003&Type=8"
        },
        {
            "title": "HEM box_30mg-107-12-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001086&Seq=001&Type=8"
        }
    ]
}